Featured Research

from universities, journals, and other organizations

Early Life Growth Spurts Protect Against 'Bad' Cholesterol

Date:
March 2, 2007
Source:
BMJ Specialty Journals
Summary:
Tall toddlers and rapidly growing teens are likely to find themselves with lower cholesterol, particularly the "bad" type, in later life, suggests research in the Journal of Epidemiology and Community Health. Conversely, piling on the pounds after the age of 15 boosted cholesterol levels, the study showed.

Tall toddlers and rapidly growing teens are likely to find themselves with lower cholesterol, particularly the "bad" type, in later life, suggests research in the Journal of Epidemiology and Community Health.

Conversely, piling on the pounds after the age of 15 boosted cholesterol levels, the study showed.

The findings are based on just under 3000 participants of a Medical Research Council long term study, tracking a representative sample of 5362 people born in one week of March in 1946.

Heights and weights were measured at the ages of 2, 4, 7, 15, 36 and 53. When participants reached the age of 53, blood samples were taken to measure cholesterol levels.

When all the figures were analysed, the results showed that the faster height was gained before the age of 2, and after the age of 15, the lower was the cholesterol level at the age of 53.

Growth in leg length, rather than trunk length, was more strongly associated with lower cholesterol levels.

Higher body fat levels at the ages of 36 and 53, and more rapid weight gain between the ages of 15 and 53, were associated with higher total cholesterol levels, including higher levels of the harmful low density lipoprotein (LDL) cholesterol.

The researchers found that the effects of the growth spurts in either height or girth could not be explained by weight at birth, which is a well known factor in adult health, or lifetime socioeconomic status.


Story Source:

The above story is based on materials provided by BMJ Specialty Journals. Note: Materials may be edited for content and length.


Cite This Page:

BMJ Specialty Journals. "Early Life Growth Spurts Protect Against 'Bad' Cholesterol." ScienceDaily. ScienceDaily, 2 March 2007. <www.sciencedaily.com/releases/2007/03/070301102718.htm>.
BMJ Specialty Journals. (2007, March 2). Early Life Growth Spurts Protect Against 'Bad' Cholesterol. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2007/03/070301102718.htm
BMJ Specialty Journals. "Early Life Growth Spurts Protect Against 'Bad' Cholesterol." ScienceDaily. www.sciencedaily.com/releases/2007/03/070301102718.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins